World Journal of Gastrointestinal Pharmacology and Therapeutics

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (505)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

HTML

210

Figures (1-3)

Tables (1-4)

Sum=267

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

136

Sum=180

Dec 5, 2025 (publication date) through Feb 11, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Colwill M, Padley J, Qazi U, Mehta S, Donovan F, Alves AM, Pollok R, Patel K, Dawson P, Honap S, Poullis A. Risankizumab is effective following ustekinumab failure in Crohn’s disease: A real-world study from a tertiary center. World J Gastrointest Pharmacol Ther 2025; 16(4): 110273 [PMID: 41378066 DOI: 10.4292/wjgpt.v16.i4.110273]
URL:	https://www.wjgnet.com/2150-5349/full/v16/i4/110273.htm

Number	Citing Articles
1	Felix Pius Omullo. Risankizumab redefines Crohn’s treatment after ustekinumab failure. World Journal of Gastrointestinal Pharmacology and Therapeutics 2026; 17(1): 114412 doi: 10.4292/wjgpt.v17.i1.114412 Abstract(3) \| Core Tip(3) \| Full Article(HTML)(9) \| Full Article with Cover (PDF)-573K(1) \| Audio-621K(1) \| Peer-Review Report-193K(2) \| Answering Reviewers-111K(1) \| Full Article (PDF)-395K(2) \| Full Article (XML)-64K(2) \| Times Cited (0) \| Total Visits (96) \| Open

Number

Citing Articles

Felix Pius Omullo. Risankizumab redefines Crohn’s treatment after ustekinumab failure. World Journal of Gastrointestinal Pharmacology and Therapeutics 2026; 17(1): 114412 doi: 10.4292/wjgpt.v17.i1.114412